and hematochezia. Th ree weeks earlier, the patient had had severe headaches and was taking 10 mg Rizatriptan orally. She reported using Rizatriptan intermittently for a few months for migraine. She did not exceed 30 mg per 24 h.
A few hours before admission, the patient had severe progressive continuous lower abdominal pain with nausea and bloody diarrhea. She reported similar milder intermittent abdominal pain for the past few months. Th e patient denied fever, syncope, dizziness, palpitation, hematemesis, and melena. She did not have a history of vasculopathy. On examination, the patient had a temperature of 37.7 ° C, pulse of 95 BPM, and blood pressure of 154 / 88. Her heart examination was normal. She had severe tenderness in the lower abdomen without rebound tenderness. Rectal examination revealed bright blood in the rectum.
Th e patient underwent a colonoscopy that showed moderate to severe colitis in the sigmoid colon, the descending colon, and the transverse colon with patchy erythema in the rectum and ascending colon ( Figure 1 ) . Th e terminal ileum was normal. Biopsies from the terminal ileum were normal. Biopsies from the sigmoid colon, descending colon, and the transverse colon showed mild acute and chronic ischemic changes indicated by acute infl ammation (1) , glandular atrophy, and fi brosis in the lamina propria. Th ere was no evidence of idiopathic infl ammatory bowel. Th e patient had normal ESR and negative ANA, ASCA, and pANCA. Th e patient had normal echocardiogram and computed tomography angiogram.
The patient was diagnosed with Rizatriptan-induced acute on top of chronic ischemic colitis. The medication was discontinued and the patient reported gradual improvement in her symptoms.
In conclusion, Rizatriptan can induce acute and chronic ischemic colitis. Medication should be avoided in patients with vascular diseases. Ischemic colitis should be considered in a patient who uses Rizatriptan and complains of abdominal pain.
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developed another episode of nausea, vomiting, and crampy abdominal pain. Th is was followed by 300 ml of hematemesis and 600 ml of hematochezia. Although stable, esophagogastroduodenoscopy ( EGD ) revealed clotted blood in the gastric body without a source, and colonoscopy showed diff use bleeding without an identifi able source. Tagged red blood cell scan showed bleeding in the transverse and ascending colon; however, angiography was unable to identify the source of bleeding.
Tweny-four hours later, he was taken to the operating room because of continued bleeding. An intraoperative endoscopy was performed, with diffuse bleeding observed in the stomach. Without an identifi able source and continued bleeding, the patient underwent gastrectomy and spelenctomy. Intraoperatively, the unknown mass seen on CT scan was found to have a vascular supply solely from the retroperitoneum. It was adherent to the spleen and attached to the liver by a thin fi brous band. Th e mass was removed with the spleen and underwent pathological analysis ( Figure 2a ).
Gross sectioning of the mass was performed by pathology ( Figure 2b ). Microscopically, this revealed tissue of hepatic origin, with mild infl ammation and early bridging fi brosis ( Figure 2c ). Aft er surgery, the patient continued to have gastrointestinal bleeding. Despite multiple attempts at stabilization, the patient was overcome by septicemia. At autopsy, microscopic examination of the right lobe of the liver revealed bridging fi brosis and incomplete cirrhosis ( Figure 2d ).
Liver tissue that is identifi ed outside of the liver is termed as either ectopic or accessory. If a visible attachment to the " mother " liver can be identifi ed, the ectopic liver is termed as an accessory lobe (1) . Although rare, with fewer than 100 cases reported, the suspected incidence ranges from 0.24 to 0.47 % (2,3) . Th ese tissues have been described in various sizes and sites, with the most common sites being attached to the gallbladder or intra-abdominal ligaments. Functionality can vary as well, ranging from fully functioning hepatic architecture with portal triads to deranged, minimally metabolic tissue with poor vascular supply, which has been hypothesized to contribute to neoplastic transformation (3) .
Th is patient ' s accessory liver was believed to be a remnant of the left hepatic lobe. With a history of chronic hepatitis B and cirrhosis, it is assumed that the left lobe atrophied and eventually obtained its vascular supply from the retroperitoneum. Th is is consistent with the fi nding of the mass with a fi brotic band, a probable capsular remnant, attached to the remaining " mother " liver. Th e vast majority of reported cases have identifi ed ectopic or accessory livers as a consequence of errors in embryologic migration (1) . A thorough literature search did not fi nd a similar presentation to the one described here, which raises the question as to whether the term accessory liver is an appropriate one.
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